This inventor holds 2 USPTO granted patents. Top assignee: Yamanouchi Pharmaceutical Company Ltd.. Active years: 1980-1983.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1980-1983
Title: Kazaharu Tamazawa: Innovator in Pharmaceutical Chemistry
Introduction
Kazaharu Tamazawa is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of penicillin and cephalosporin derivatives. With a total of 2 patents, his work has had a considerable impact on the industry.
Latest Patents
Tamazawa's latest patents include innovative compounds that serve as intermediates for the preparation of highly effective antibiotics. His first patent, titled "1,3-Dithietane-2-carboxylic acid penicillin and cephalosporin derivatives," focuses on substituted 1,3-dithietane-2-carboxylic acid derivatives. These derivatives are crucial for creating potent penicillin and cephalosporin medications. The second patent, "1,3-Dithietane-2-carboxylic acids and the preparation thereof," also emphasizes the importance of these substituted derivatives in pharmaceutical applications.
Career Highlights
Kazaharu Tamazawa is currently associated with Yamanouchi Pharmaceutical Company Ltd., where he continues to advance his research and development efforts. His work has been instrumental in enhancing the efficacy of antibiotic treatments, thereby contributing to public health.
Collaborations
Throughout his career, Tamazawa has collaborated with esteemed colleagues such as Masaru Iwanami and Tetsuya Maeda. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Kazaharu Tamazawa's contributions to pharmaceutical chemistry, particularly through his patents, highlight his role as a key innovator in the field. His work continues to influence the development of effective antibiotics, showcasing the importance of research and collaboration in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile